Durable response using regorafenib in an elderly patient with metastatic colorectal cancer: case report
Ronald Tang,1 Tatiana Kain,2 June Herman,2 Tara Seery1 1Division of Hematology-Oncology, 2Division of Nuclear Medicine and Molecular Imaging, University of California, Irvine, Orange, CA, USA Abstract: Regorafenib, an oral multikinase inhibitor, was approved in September 2012 by the US Food and Dru...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-11-01
|
| Series: | Cancer Management and Research |
| Online Access: | https://www.dovepress.com/durable-response-using-regorafenib-in-an-elderly-patient-with-metastat-peer-reviewed-article-CMAR |